New Breakthrough for ALS Patients
Researchers at New York University say they've identified a way to slow the effects of ALS, also known as Lou Gehrig's disease.
The debilitating condition attacks nerve cells of the brain and spinal cord.
Researchers found that when they tripled a specific protein in mice, nerve cells stayed attached to muscle longer.
Scientists say this could give ALS patients more mobility, but the study did not show the mice lived longer.
On average, ALS patients die within three years of diagnosis because the muscles that keep them breathing lose connection to the nerves and stop working.